Please provide your email address to receive an email when new articles are posted on . The approval is based on four studies in which neffy provided comparable epinephrine delivery to current ...

"Market research has shown that there is an unmet need for more patient-friendly alternatives to traditional epinephrine auto-injectors," said David Dworaczyk, Ph.D., CEO of Bryn Pharma. "This study ...

Findings accepted for publication in the official journal of the American College of Allergy, Asthma and Immunology About 9 out of every 10 patients experiencing anaphylaxis were effectively treated ...

(CNN) — The US Food and Drug Administration approved the first nasal spray epinephrine drug for severe allergic reactions known as anaphylaxis, providing a needle-free alternative to EpiPens and ...

SAN DIEGO, March 05, 2025 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves ...

Share on Facebook. Opens in a new tab or window Share on Twitter. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window It is the second time in a week that EMS has brought a ...

The availability of neffy 1 mg extends protection to younger, school-aged children—who make up nearly 23% of people needing epinephrine Visit neffy.com for savings and support programs and pay as ...

Although many parents of infants worry about their child having a food allergy, there has not been a lot of research into the presentation of anaphylaxis in infants. A new study being presented at ...

A lack of clinical efficacy data on epinephrine nasal spray remained a chief concern for FDA reviewers as the agency considers approval of the first noninjectable product for treating allergic ...

Credit: ARS Pharma. Neffy is supplied as a single-dose (2mg of epinephrine) nasal spray that is administered into 1 nostril. With regard to cardiovascular effects, increases in blood pressure and ...